Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia

American Journal of Medicine

Volumn 100, Issue 1, 1996, Pages 17-23

  Anaissie, Elias J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLAVULANIC ACID; NETILMICIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TICARCILLIN; TIMENTIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEVER; HUMAN; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SUPERINFECTION; SURVIVAL RATE;

EID: 0030058402     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)90006-6     Document Type: Article

References (2)

1. Meunier F. Infections in patients with acute leukemia and lymphoma. In: Mandell GL, Douglas RG Jr., Bennett JE, eds. Principles and Practice of Infectious Diseases. New York; Churchill Livingstone:1990;2-55
2. Anaissie E, Fainstein V, Bodey GP, et al. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients. Am J Med. 1988;84:581-589.